Gastric Inhibitory Polypeptide (3-42) (human)

Gastric Inhibitory Polypeptide (3-42) (human), the main physiological degradation product of gastric inhibitory polypeptide (GIP), is produced by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV). It is a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist that regulates insulin secretion and GIP metabolism in vivo.
Supplier BOC Sciences
Product # BAT-014467
Pricing Inquire
Cas 1802086-25-4
Molecular Weight 4749.35
Molecular Formula C214H324N58O63S
Feedback